As CA 19-9 has proven to be a sensitive marker in diagnostics and control of the development of pancreatic carcinoma, the authors compared in a prospective study in 441 patients (93 patients with colorectal carcinoma, 57 patients with carcinoma of the stomach, ten patients with oesophageal carcinoma, 45 patients with malignancies outside the gastrointestinal tract, 236 patients with benign general surgical diseases) the value of the marker CA 19-9 with CEA in the diagnosis of carcinomata of the stomach and colon/rectum. It was demonstrated that CEA has a higher sensitivity than CA 19-9 in all stages of carcinomata of the stomach and colon/rectum.
|Translated title of the contribution||CA 19-9 in the diagnosis of gastric and colorectal carcinoma|
|Number of pages||4|
|Publication status||Published - Jan 1 1985|
ASJC Scopus subject areas